ScreenerHero

CLGN CollPlant Biotechnologies Ltd.

NAS · US · Healthcare · Biotechnology · collplant.com
3.970USD+14.74%Mkt Cap: 7.51M $P/E: —

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap7.51M USD
Enterprise Value5.84M USD
Revenue (TTM)318.00K USD
Gross Profit1.54M USD
Net Income (TTM)-11.49M USD
Revenue/Share0.24 USD
Last Price3.970 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees39
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.18
PEG—
EV/EBITDA-0.51
EV/Revenue18.35
P/S23.61
P/B1.95
EPS (TTM)-10.74
EPS (Forward)-0.39
52W Range
2.6376% of range26.80
52W High26.80 USD
52W Low2.637 USD
Profitability
Gross Margin64.78%
Oper. Margin-2437.96%
EBITDA Margin0.00%
Profit Margin-484.56%
ROE-188.93%
ROA-106.53%
Growth
Revenue Growth-39.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.42M USD
CapEx (TTM)28.00K USD
FCF Margin-2168.24%
FCF Yield-91.85%
Net Debt101.00K USD
Net Debt/EBITDA-0.01
Balance Sheet
Debt/Equity0.47
Current Ratio1.57
Quick Ratio1.19
Book Value/Sh2.04 USD
Cash/Share1.77 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 21, 2016
Splits
Last Split1:10
Split DateSep 4, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.89M
Float869.60K
Insiders33.56%
Institutions9.93%
Short Interest
Short Ratio0.1d
Short % Float3.47%
Short % Out.2.76%
Shares Short52.24K
Short (prev mo.)2.19K
Technical
SMA 503.446 (+15.2%)
SMA 2006.049 (-34.4%)
Beta0.76
S&P 52W Chg15.84%
Avg Vol (30d)125.55K
Avg Vol (10d)33.61K
Technical Indicators
RSI (14)56.8
MACD0.0353
MACD Signal0.0789
MACD Hist.-0.0436
BB Upper4.463 USD
BB Middle3.758 USD
BB Lower3.053 USD
BB Width37.53%
ATR (14)0.4270 USD
Vol Ratio (20d)0.79x